| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 32.89% | Telsey Advisory Group | → $4 | Reiterates | Outperform → Outperform |
| 08/10/2023 | 32.89% | Morgan Stanley | $2.25 → $4 | Maintains | Equal-Weight |
| 08/10/2023 | 32.89% | Goldman Sachs | $3 → $4 | Maintains | Neutral |
| 08/09/2023 | 32.89% | Goldman Sachs | $3 → $4 | Maintains | Neutral |
| 08/09/2023 | 32.89% | Telsey Advisory Group | → $4 | Reiterates | Outperform → Outperform |
| 08/01/2023 | 32.89% | Telsey Advisory Group | → $4 | Reiterates | Outperform → Outperform |
| 05/11/2023 | -0.33% | Goldman Sachs | $2 → $3 | Maintains | Neutral |
| 05/10/2023 | 32.89% | Telsey Advisory Group | $3 → $4 | Maintains | Outperform |
| 05/10/2023 | 32.89% | Wedbush | $3 → $4 | Maintains | Outperform |
| 05/10/2023 | 66.11% | Wells Fargo | $4 → $5 | Maintains | Overweight |
| 05/10/2023 | -0.33% | Goldman Sachs | $2 → $3 | Maintains | Neutral |
| 05/10/2023 | -25.25% | Morgan Stanley | $1 → $2.25 | Maintains | Equal-Weight |
| 05/02/2023 | -0.33% | Telsey Advisory Group | → $3 | Reiterates | → Outperform |
| 03/07/2023 | 66.11% | Needham | → $5 | Reiterates | → Buy |
| 03/07/2023 | -0.33% | Telsey Advisory Group | → $3 | Reiterates | → Outperform |
| 02/28/2023 | -0.33% | Telsey Advisory Group | → $3 | Reiterates | → Outperform |
| 11/16/2022 | -33.55% | Goldman Sachs | $4 → $2 | Maintains | Neutral |
| 11/15/2022 | -66.78% | Morgan Stanley | $1.75 → $1 | Maintains | Equal-Weight |
| 11/15/2022 | 32.89% | Wells Fargo | $12 → $4 | Maintains | Overweight |
| 11/15/2022 | 32.89% | Raymond James | $7 → $4 | Maintains | Outperform |
| 11/15/2022 | -33.55% | Piper Sandler | $3.5 → $2 | Maintains | Neutral |
| 11/15/2022 | 66.11% | Needham | $10 → $5 | Maintains | Buy |
| 10/25/2022 | -41.86% | Morgan Stanley | $4 → $1.75 | Maintains | Equal-Weight |
| 08/16/2022 | 32.89% | Goldman Sachs | $6 → $4 | Maintains | Neutral |
| 08/16/2022 | 66.11% | Barclays | $6 → $5 | Maintains | Overweight |
| 08/16/2022 | 32.89% | Morgan Stanley | $9 → $4 | Maintains | Equal-Weight |
| 08/16/2022 | 132.56% | Telsey Advisory Group | $11 → $7 | Maintains | Outperform |
| 08/15/2022 | 99.34% | Barclays | $9 → $6 | Maintains | Overweight |
| 07/21/2022 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 06/30/2022 | 132.56% | Raymond James | → $7 | Initiates Coverage On | → Outperform |
| 06/10/2022 | 99.34% | Goldman Sachs | $10 → $6 | Maintains | Neutral |
| 05/10/2022 | 199% | Barclays | $14 → $9 | Maintains | Overweight |
| 05/10/2022 | 398.34% | Wells Fargo | $20 → $15 | Maintains | Overweight |
| 05/10/2022 | 232.23% | Needham | $25 → $10 | Maintains | Buy |
| 05/10/2022 | 265.45% | Telsey Advisory Group | $19 → $11 | Maintains | Outperform |
| 04/25/2022 | — | Goldman Sachs | Downgrades | Buy → Neutral | |
| 03/18/2022 | 331.89% | Jefferies | → $13 | Initiates Coverage On | → Buy |
| 03/08/2022 | 199% | Morgan Stanley | $16 → $9 | Maintains | Equal-Weight |
| 03/08/2022 | 531.23% | Piper Sandler | $34 → $19 | Maintains | Overweight |
| 02/17/2022 | 564.45% | Wells Fargo | $30 → $20 | Maintains | Overweight |
| 01/20/2022 | 498.01% | Keybanc | $32 → $18 | Maintains | Overweight |
| 11/23/2021 | 730.56% | Guggenheim | → $25 | Initiates Coverage On | → Buy |
| 11/09/2021 | 797.01% | Barclays | $23 → $27 | Maintains | Overweight |
| 10/05/2021 | 730.56% | Wedbush | → $25 | Initiates Coverage On | → Outperform |
| 09/28/2021 | 597.67% | Berenberg | → $21 | Initiates Coverage On | → Hold |
| 07/28/2021 | 531.23% | Morgan Stanley | $16 → $19 | Maintains | Equal-Weight |
| 07/27/2021 | 963.12% | Telsey Advisory Group | $22 → $32 | Maintains | Outperform |
| 07/08/2021 | 1062.79% | Needham | → $35 | Initiates Coverage On | → Buy |
| 06/17/2021 | 963.12% | Keybanc | $22 → $32 | Maintains | Overweight |
| 05/13/2021 | 763.79% | Wells Fargo | $22 → $26 | Maintains | Overweight |
| 05/13/2021 | 630.9% | Telsey Advisory Group | $20 → $22 | Maintains | Outperform |
| 05/13/2021 | 564.45% | Barclays | $19 → $20 | Maintains | Overweight |
| 04/20/2021 | 630.9% | Wells Fargo | → $22 | Initiates Coverage On | → Overweight |
| 04/20/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 04/20/2021 | 564.45% | Piper Sandler | → $20 | Initiates Coverage On | → Overweight |
| 04/20/2021 | 564.45% | Goldman Sachs | → $20 | Initiates Coverage On | → Buy |
| 04/20/2021 | 431.56% | Morgan Stanley | → $16 | Initiates Coverage On | → Equal-Weight |
| 04/20/2021 | 531.23% | Barclays | → $19 | Initiates Coverage On | → Overweight |
| 04/20/2021 | 630.9% | Keybanc | → $22 | Initiates Coverage On | → Overweight |
| 04/20/2021 | 564.45% | Telsey Advisory Group | → $20 | Initiates Coverage On | → Outperform |
What is the target price for ThredUp (TDUP)?
The latest price target for ThredUp (NASDAQ: TDUP) was reported by Telsey Advisory Group on October 31, 2023. The analyst firm set a price target for $4.00 expecting TDUP to rise to within 12 months (a possible 32.89% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ThredUp (TDUP)?
The latest analyst rating for ThredUp (NASDAQ: TDUP) was provided by Telsey Advisory Group, and ThredUp reiterated their outperform rating.
When is the next analyst rating going to be posted or updated for ThredUp (TDUP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ThredUp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ThredUp was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
Is the Analyst Rating ThredUp (TDUP) correct?
While ratings are subjective and will change, the latest ThredUp (TDUP) rating was a reiterated with a price target of $0.00 to $4.00. The current price ThredUp (TDUP) is trading at is $3.01, which is within the analyst's predicted range.